A Guide to Prevention, Symptoms, Treatments and
Hope ... Answers to questions you have about cancer broken down in plain English...
|
cancer mesothelioma or cancer ovarian symptom and cancer lung symptom not cancer colon symptom but cancer prostate and cancer prostate treatment not breast cancer or cancer |
 |
What You Don't Know About Cancer Could Be
Deadly
|
|
De-mystifying Cancer
by Stuart Wolfe
|
From: Dean Brenner
Date: Tuesday, December 2, 2008 |
| |
By The Time You Are Diagnosed - Will It Be Too Late?
Are you playing Russian Roulette with your health? Do you suspect that you
may have cancer but have been ignoring the symptoms hoping they will just go away?
It's hard to believe that people would actually ignore something that important,
doesn't it? But it happens. Thousands of people die every day of cancer related
illness.
The sad thing is that many of those premature deaths could have been avoided
with just a little bit of knowledge and early detection.
The major problem with much of the information about cancer is that it is very
general and written in medical jargon that is nearly impossible to decipher. That's
where De-mystifying Cancer comes in.
De-mystifying Cancer has taken all that technical information
and broken it down in plain English so that anyone can get answers to their burning
questions.
Questions like these:
- What is cancer?
- How does it develop?
- What are the major types of cancer?
- What are primary and secondary cancers?
- What are carcinomas, sarcomas, leukemia, lymphomas and adenomas?
- How is your immune system affected by cancer?
- Who gets cancer?
- What are the signs and symptoms of cancer?
- What are the risk factors for cancer?
- How do you diagnose lung cancer in men and women?
- Are you at risk for prostate cancer?
- How can you detect breast cancer in its early stages?
- What imaging processes are used for detecting cancer?
- What are the different types of biopsies?
- Do you know what treatment options are available?
- Are there alternative treatments and therapies?
And that just scratches the surface. De-mystifying Cancer
is jam-packed with answers to every question you could possibly have about cancer.
One of the most important things you will find inside is an Action Plan for
Coping With a cancer diagnosis. This section will help you:
- Inform yourself
- How to choose the right doctor
- How to communicate with your family members
- Innovative approaches to treatment
- Changing your diet
- How to continue with your normal daily life
Don't put it off any longer. If you suspect that you or a loved one may have
cancer and need answers to those burning questions, De-mystifying Cancer
is just what you need.
Don't wait until it's too late. Get your copy now!
Stuart Wolfe (Author) |
cancer mesothelioma because cancer ovarian symptom and cancer lung symptom and cancer colon symptom the cancer prostate maybe cancer prostate treatment and breast cancer maybe cancer |
| |
|
|
| |
| |
|
|
| |
| |
 |
| |
| |
Our 365-day Guarantee! If you're not 100% completely satisfied, we'll
return 100% of everything you paid.
It's the best guarantee in the business!
We want you to be a happy customer ... If for any reason you are not completely satisfied with the De-mystifying Cancer,
just drop us a line (our full details are at the bottom of this page) with a copy of your sales receipt and we'll gladly refund your
full purchase amount. No questions asked ... No hassles ... And we can still be friends...
Now that's more than a guarantee ... It's our personal promise to you. |
| |
| |
|
| |
| |
Here are two easy ways to order:
Order
De-mystifying Cancer online
... immediate download Order De-mystifying Cancer by mail
|
| |
|
| |
| |
| |
To your success!
Dean Brenner
Webmaster
BWS Group |
| |
| |
| P.S. Don't wait until you or a loved one becomes a statistic. Get your
copy now and get your answers right away. |
| |
| |
|
|
| |
| |
|
|
| |
| |
| |
| Check Out These Other Great Health Related Titles Click a title to visit the product website* |
| |
* Note: A new browser window will open. When finished viewing,
close the new browser window and you will be returned here. |
|
| |
Click a title to visit the product website*
|
| | | | |
Do you need more Health-Related information?
Take a look at Improve Your Life. You will be sure to find it there ...
and at a nice bargain-basement price as well.
|
| |
* Note: A new browser window will open. When finished viewing,
close the new browser window and you will be returned here. |
|
| | | |
|
|
| |
| |
|
| |
| |
|
|
| |
|
|
| |
| |
| Cancer / Oncology News Informational Articles |
| |
Tue, 02 Dec 2008 04:00:00 PST
Five Steps To Saving Lives And Improving Men's Experience Of Prostate Cancer By 2020
The Prostate Cancer Charity is launching a new strategy 'Transforming The Future For Prostate Cancer' - which it believes could reduce mortality rates by 30 per cent. The strategy, which will be unveiled at a special event next Monday (1 December), outlines ambitious goals and targets for vital changes the Charity believes are necessary to improve men's experience of prostate cancer by 2020. | | | Tue, 02 Dec 2008 04:00:00 PST
Breakthrough Breast Cancer In Response To The Publication Of The Cancer Reform Strategy 1 Year On Report Published By The Department Of Health Today
Jeremy Hughes, Chief Executive of Breakthrough Breast Cancer says: "The Cancer Reform Strategy (CRS) has made steady progress since its publication last year. Breakthrough is particularly delighted to see our Service Pledge for Breast Cancer - a tool developed to enable health professionals and patients work together towards improved breast cancer services - is highlighted in today's report. | | | Tue, 02 Dec 2008 03:00:00 PST
Nationwide Study Confirms PET As The Most Powerful Imaging Tool In Cancer Management
With the most recent release of data from the National Oncologic PET Registry (NOPR), researchers may have reached the moment of critical mass by confirming the effectiveness of positron emission tomography (PET) in the monitoring of tumor activity across a wide range of cancers. | | | Tue, 02 Dec 2008 03:00:00 PST
Ark Files Cerepro(R) Application For Marketing Authorisation With EMEA
Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") today announces that the Marketing Authorisation Application (MAA) for Cerepro®, Ark's novel gene-based therapy for operable malignant glioma (brain cancer), has been filed with the European medicines regulatory agency (EMEA). The MAA application for Cerepro®, filed following a pre-submission meeting with the EMEA, will now enter the validation stage, prior to commencing formal review. | | | Tue, 02 Dec 2008 01:00:00 PST
Study Demonstrates The Benefit Of Using Chemoradiotherapy In Elderly Patients With Locally Advanced Oesophageal Cancer
Chemoradiotherapy (CRT) can be considered an "effective" treatment for elderly patients with locally advanced oesophageal cancer, reports the British Journal of Cancer. The French study, involving 109 consecutive patients with oesophageal cancer, suggests that characterising patients first with the "Charlson" score may provide useful criteria for deciding which subjects are suitable for treatment. | | | Tue, 02 Dec 2008 01:00:00 PST
Wistar Scientists Find Key To Keeping Killer T Cells In Prime Shape For Fighting Infection, Cancer
Like tuning a violin to produce strong, elegant notes, researchers at The Wistar Institute have found multiple receptors on the outside of the body's killer immune system cells which they believe can be selectively targeted to keep the cells in superb infection- and disease-fighting condition. | | | Tue, 02 Dec 2008 01:00:00 PST
IDO2 An Active Enzyme To Target In Pancreatic Cancer
An enzyme that is overexpressed in pancreatic cancer cells may hold the key to successfully treating the disease with targeted immunotherapy, researchers from Thomas Jefferson University reported at the 2008 Annual Meeting of the Southern Surgical Association. Previous data show that a protein, indoleamine 2,3-dioxygenase (IDO), is overexpressed in pancreatic ductal adenocarcinomas, according to Jonathan R. Brody, Ph.D. | | | Tue, 02 Dec 2008 00:00:00 PST
Vical Receives Milestone Payment From Merck & Co., Inc. Triggered By Planned Initiation Of Investigational Cancer DNA Vaccine Trial
Vical Incorporated (Nasdaq: VICL) announced the receipt of a $1.0 million milestone payment from Merck & Co., Inc. based on Merck's planned initiation of a Phase I clinical trial of an investigational plasmid DNA (pDNA) cancer vaccine. The candidate vaccine is based on Vical's DNA gene delivery technology and encodes human telomerase reverse transcriptase (hTERT). hTERT is the subject of separate license agreement. | | | Mon, 01 Dec 2008 09:00:00 PST
Marshall Edwards, Inc. Files IND Application For Triphendiol - Locally Advanced Or Metastatic Pancreatic And Bile Duct Cancers
Marshall Edwards, Inc. (NASDAQ: MSHL) today announced that it has filed an application with the United States Food and Drug Administration for an Investigative New Drug (IND) approval to undertake clinical studies with triphendiol as a chemosensitizing agent in combination with gemcitabine. | | | Mon, 01 Dec 2008 08:00:00 PST
Earlier Detection Of Cancer And Better Treatment For Survivors, UK
Work is well underway to catch more cancer cases earlier and improve the longer term treatment for cancer survivors, National Cancer Director Professor Mike Richards said today. The first annual report setting out the Government's progress against the Cancer Reform Strategy, "Maintaining Momentum, Building for the Future", highlights the achievements made in the first year and identifies priorities for the year ahead. | | |
|
| |
|
| |
| |
| * Any testimonials and/or examples used may be exceptional results which may not apply to the average person.
They are not intended to represent or guarantee that anyone who purchases and/or uses this product will acheive the same or similar
results. Each individual's success depends on their background, dedication, desire and motivation. |
bonus points
